ClinicalTrials.Veeva

Menu

Fluid Agitation Microbiologic Yield In Pleural Infection Feasibility Study (FLAG-PINS)

A

Alexandria University

Status

Completed

Conditions

Pleural Infection

Treatments

Procedure: Agitated Pleural Fluid Thoracentesis

Study type

Interventional

Funder types

Other

Identifiers

NCT05702580
0107486

Details and patient eligibility

About

The goal of this study is to compare the microbiologic diagnostic yield of pre-aspiration agitated pleural fluid versus that of conventionally aspirated fluid in pleural infection patients. The main question it aims to answer is, whether fluid agitation helps to increase the microbiological yield.

Full description

In pleural infection, It is suggested that the bacteria being diagnostically targeted, might more likely be residing on the pleural surface with a better blood supply and nutrition rather than being planktonic in the acidic, glucose deficient pleural fluid. The investigators thus hypothesize that an agitation of the pleural fluid prior to sample aspiration would aid in achieving a better cellular representation of the pleural space. This could have the effect of washing bacterial cells off the pleural surface as well as moving sedimented cells in the aspirated sample. This study aims to investigate whether an increase in the microbiological yield for infected pleural fluid could be achieved by a pre-aspiration agitation of the pleural fluid which would have a positive effect on management and eventual patient outcomes. Adult participants with pleural infection will undergo thoracentesis via both the standard and agitated fluid techniques guided by thoracic ultrasound. Microbiological yields will be compared.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age >18 years old
  2. Pleural infection based on clinical presentation, imaging or laboratory investigations and pleural fluid examination showing glucose < 40 mg/dL or pH <7.2 with lower respiratory infection or pus on aspiration
  3. At least a moderate amount of pleural fluid collection (2 or more intercostal spaces on thoracic ultrasound)

Exclusion criteria

  1. Minimal - mild pleural fluid deemed unsuitable for aspiration and agitation
  2. Hemodynamic instability
  3. Uncorrected coagulopathy
  4. Transudative or exudative lymphocytic pleural effusion on biochemical analysis

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Standard thoracentesis followed by pre-aspiration fluid agitation
Experimental group
Description:
Participants will undergo the standard thoracentesis followed by the experimental pre-aspiration fluid agitation technique
Treatment:
Procedure: Agitated Pleural Fluid Thoracentesis

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed S Sadaka, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems